Connection

Brian Hess to Antibodies, Monoclonal

This is a "connection" page, showing publications Brian Hess has written about Antibodies, Monoclonal.
Connection Strength

0.173
  1. Efficacy of tixagevimab-cilgavimab in preventing SARS-CoV-2 for patients with B-cell malignancies. Blood. 2023 01 12; 141(2):200-203.
    View in: PubMed
    Score: 0.173
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.